Clinical Trial

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess how fast BGM0504 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-08; most recent amendment 2026-02-09.
Status change: Recruiting → Completed 2026-02-09
Trial Details
NCT Number NCT06929156
Lead Sponsor BrightGene Bio-Medical Technology Co., Ltd.
Conditions Type 2 Diabetes Mellitus (T2DM), Overweight or Obese
Enrollment 34 participants
Start Date 2025-05-06
Primary Completion 2025-12-25 (estimated)
Study Completion 2025-12-25 (estimated)
Updated on ClinicalTrials.gov 2026-02-11